Treatment of acute hallucinogenic drug toxicity: specific pharmacological intervention.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D001532:Atropa belladonna / Q000037:antagonists & inhibitors / Q000506:poisoning; D002746:Chlorpromazine / Q000627:therapeutic use; D013759:Dronabinol / Q000037:antagonists & inhibitors / Q000506:poisoning; D006213:Hallucinogens / Q000037:antagonists & inhibitors* / Q000633:toxicity; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000037:antagonists & inhibitors / Q000506:poisoning; D008635:Mescaline / Q000037:antagonists & inhibitors / Q000506:poisoning; D010276:Parasympatholytics / Q000037:antagonists & inhibitors / Q000506:poisoning; D010622:Phencyclidine / Q000037:antagonists & inhibitors / Q000506:poisoning; D010627:Phenethylamines / Q000506:poisoning; D010830:Physostigmine / Q000627:therapeutic use; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011041:Poisoning / Q000188:drug therapy; D013386:Succinates / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D006213:Hallucinogens; D010276:Parasympatholytics; D010627:Phenethylamines; D013386:Succinates; D014149:Tranquilizing Agents; D013759:Dronabinol; D008238:Lysergic Acid Diethylamide; D010830:Physostigmine; D000661:Amphetamine; D010622:Phencyclidine; D008635:Mescaline; D002746:Chlorpromazine